Darlene A Dartt1, Sharmila Masli. 1. aDepartment of Ophthalmology, Schepens Eye Research Institute/Massachusetts Eye and Ear, Harvard Medical School bDepartment of Ophthalmology, Boston University School of Medicine, Boston, Massachusetts, USA.
Abstract
PURPOSE OF REVIEW: Although conjunctival goblet cells are a major cell type in ocular mucosa, their responses during ocular allergy are largely unexplored. This review summarizes the recent findings that provide key insights into the mechanisms by which their function and survival are altered during chronic inflammatory responses, including ocular allergy. RECENT FINDINGS: Conjunctiva represents a major component of the ocular mucosa that harbors specialized lymphoid tissue. Exposure of mucin-secreting goblet cells to allergic and inflammatory mediators released by the local innate and adaptive immune cells modulates proliferation, secretory function, and cell survival. Allergic mediators like histamine, leukotrienes, and prostaglandins directly stimulate goblet cell mucin secretion and consistently increase goblet cell proliferation. Goblet cell mucin secretion is also detectable in a murine model of allergic conjunctivitis. Additionally, primary goblet cell cultures allow evaluation of various inflammatory cytokines with respect to changes in goblet cell mucin secretion, proliferation, and apoptosis. These findings in combination with the preclinical mouse models help understand the goblet cell responses and their modulation during chronic inflammatory diseases, including ocular allergy. SUMMARY: Recent findings related to conjunctival goblet cells provide the basis for novel therapeutic approaches, involving modulation of goblet cell mucin production, to improve treatment of ocular allergies.
PURPOSE OF REVIEW: Although conjunctival goblet cells are a major cell type in ocular mucosa, their responses during ocular allergy are largely unexplored. This review summarizes the recent findings that provide key insights into the mechanisms by which their function and survival are altered during chronic inflammatory responses, including ocular allergy. RECENT FINDINGS: Conjunctiva represents a major component of the ocular mucosa that harbors specialized lymphoid tissue. Exposure of mucin-secreting goblet cells to allergic and inflammatory mediators released by the local innate and adaptive immune cells modulates proliferation, secretory function, and cell survival. Allergic mediators like histamine, leukotrienes, and prostaglandins directly stimulate goblet cell mucin secretion and consistently increase goblet cell proliferation. Goblet cell mucin secretion is also detectable in a murine model of allergic conjunctivitis. Additionally, primary goblet cell cultures allow evaluation of various inflammatory cytokines with respect to changes in goblet cell mucin secretion, proliferation, and apoptosis. These findings in combination with the preclinical mouse models help understand the goblet cell responses and their modulation during chronic inflammatory diseases, including ocular allergy. SUMMARY: Recent findings related to conjunctival goblet cells provide the basis for novel therapeutic approaches, involving modulation of goblet cell mucin production, to improve treatment of ocular allergies.
Authors: Ivan J Fuss; Frank Heller; Monica Boirivant; Francisco Leon; Masaru Yoshida; Stefan Fichtner-Feigl; Zhiqiong Yang; Mark Exley; Atsushi Kitani; Richard S Blumberg; Peter Mannon; Warren Strober Journal: J Clin Invest Date: 2004-05 Impact factor: 14.808
Authors: Marie A Shatos; Jian Gu; Robin R Hodges; Kameran Lashkari; Darlene A Dartt Journal: Invest Ophthalmol Vis Sci Date: 2008-04-17 Impact factor: 4.799
Authors: Barbara E Caffery; Elizabeth Joyce; Miriam L Heynen; Robert Ritter; Lyndon A Jones; Michelle Senchyna Journal: Optom Vis Sci Date: 2014-02 Impact factor: 1.973
Authors: Geraint P Williams; Paul J Tomlins; Alastair K Denniston; H Susan Southworth; Sreekanth Sreekantham; S John Curnow; Saaeha Rauz Journal: Invest Ophthalmol Vis Sci Date: 2013-07-10 Impact factor: 4.799
Authors: Hanna-Mari Jauhonen; Jarmo Laihia; Olli Oksala; Johanna Viiri; Reijo Sironen; Päivi Alajuuma; Kai Kaarniranta; Lasse Leino Journal: Graefes Arch Clin Exp Ophthalmol Date: 2017-08-24 Impact factor: 3.117
Authors: Nora Botten; Robin R Hodges; Dayu Li; Jeffrey A Bair; Marie A Shatos; Tor P Utheim; Charles N Serhan; Darlene A Dartt Journal: FASEB J Date: 2019-04-23 Impact factor: 5.191
Authors: Cuiyan Tan; Wambui S Wandu; Anthony St Leger; Jennifer Kielczewski; Eric F Wawrousek; Chi-Chao Chan; Igal Gery Journal: Exp Eye Res Date: 2017-10-24 Impact factor: 3.467
Authors: Markus V Olsen; Anne V Lyngstadaas; Jeffrey A Bair; Robin R Hodges; Tor P Utheim; Charles N Serhan; Darlene A Dartt Journal: J Cell Physiol Date: 2020-06-08 Impact factor: 6.384